Announced Sun, 21 Sept · 14:49 IST

Proceedings of AGM held on September 21, 2025 through VC/OVAM.

Board & Shareholder Meetings View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Mardia Samyoung Capillary Tubes Company Ltd held its 33rd AGM on September 21, 2025 via video conferencing. Ordinary resolutions were passed to adopt the FY25 (ended March 31, 2025) Balance Sheet and Profit & Loss Account, and to re-appoint Mr. Dhaval Dharmendrabhai Joshi as Director (retiring by rotation). Several special resolutions were also approved, including the appointment of SCS & CO. LLP as Secretarial Auditors, Mr. Keyur Kiritkumar Saxsena as Non-Executive Director, and Ms. Sonal Vaghela and Mr. Jaykumar Bhaveshkumar Patel as Independent Directors. Major corporate changes approved include shifting the registered office from Mumbai (Maharashtra) to Ahmedabad (Gujarat), altering the Object Clause of the MOA, and adopting entirely new sets of MOA and Articles of Association.

Likely market impact

This is a procedural disclosure confirming shareholder approvals and is unlikely to move the stock on its own. The shift of registered office from Maharashtra to Gujarat, along with changes to the company's main objects and constitutional documents, signals a possible strategic or operational pivot worth watching. Investors should await the detailed voting results (to be filed separately) for clarity on shareholder sentiment.